Analytical Methods for Biologics

Human Oligosaccharide studies typically employ techniques such as CD, Nuclear Magnetic Resonance (NMR), and High-Definition Mass Spectrometry (HDX-MS) to characterize the glycan profile of the biologic.

Glycan analysis is often conducted using capillary electrophoresis coupled with liquid chromatography – mass spectrometry (CE/LC-MS profiling). This method allows for detailed characterization of the glycans present, including their structure and abundance.

Impurity analysis focuses on identifying and quantifying potential contaminants such as heavy chain polylactosines (HCP), DNA fragments, and leachables from packaging materials. These impurities are carefully monitored to ensure patient safety.

Forced degradation studies are performed under various stress conditions – such as heat, light, and humidity – to assess the stability of the biologic over time. This data is used to establish appropriate storage conditions and shelf life.

Comparative analytics are essential when developing biosimilars, focusing on pre- and post-change analytical methods to detect any differences introduced during the manufacturing process. These changes must be thoroughly investigated and justified.

Standards and controls play a crucial role in ensuring the accuracy and reliability of analytical measurements. These standards are carefully characterized and validated to serve as benchmarks for comparison.

High-throughput laboratories utilizing automated systems can significantly accelerate the analytical process, improving efficiency and reducing human error in biologic testing.

The International Council for Harmonisation (ICH) Q6B guidance provides a framework for developing and validating analytical methods used in biologic drug development and manufacturing.

Maintaining the integrity and traceability of all analytical data is paramount, employing robust data management systems to ensure accuracy, reproducibility, and compliance with regulatory requirements.

The future of biologic analytics lies in the development of orthogonal, rapid assays that provide comprehensive characterization while minimizing turnaround time for critical quality assessments.